KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $652,000 | +3.5% | 108,884 | +0.9% | 0.00% | 0.0% |
Q1 2019 | $630,000 | -37.7% | 107,949 | 0.0% | 0.00% | -33.3% |
Q4 2018 | $1,011,000 | -47.6% | 107,949 | -4.8% | 0.00% | -40.0% |
Q3 2018 | $1,930,000 | +0.2% | 113,349 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $1,926,000 | +66.2% | 113,349 | +31.2% | 0.01% | +66.7% |
Q1 2018 | $1,159,000 | +47.8% | 86,376 | +5.8% | 0.00% | +50.0% |
Q4 2017 | $784,000 | -9.7% | 81,670 | +3.3% | 0.00% | -33.3% |
Q3 2017 | $868,000 | +24.4% | 79,055 | +2.5% | 0.00% | +50.0% |
Q2 2017 | $698,000 | -26.2% | 77,105 | +4.6% | 0.00% | -33.3% |
Q1 2017 | $946,000 | +32.7% | 73,685 | -2.9% | 0.00% | +50.0% |
Q4 2016 | $713,000 | – | 75,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |